1. Home
  2. LEXX vs BCG Comparison

LEXX vs BCG Comparison

Compare LEXX & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • BCG
  • Stock Information
  • Founded
  • LEXX 2004
  • BCG 2016
  • Country
  • LEXX Canada
  • BCG United States
  • Employees
  • LEXX N/A
  • BCG N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • BCG
  • Sector
  • LEXX Health Care
  • BCG
  • Exchange
  • LEXX Nasdaq
  • BCG Nasdaq
  • Market Cap
  • LEXX 39.1M
  • BCG 42.3M
  • IPO Year
  • LEXX N/A
  • BCG N/A
  • Fundamental
  • Price
  • LEXX $1.45
  • BCG $1.90
  • Analyst Decision
  • LEXX Strong Buy
  • BCG
  • Analyst Count
  • LEXX 2
  • BCG 0
  • Target Price
  • LEXX $9.50
  • BCG N/A
  • AVG Volume (30 Days)
  • LEXX 110.6K
  • BCG 40.4K
  • Earning Date
  • LEXX 04-08-2025
  • BCG 03-03-2025
  • Dividend Yield
  • LEXX N/A
  • BCG N/A
  • EPS Growth
  • LEXX N/A
  • BCG N/A
  • EPS
  • LEXX N/A
  • BCG N/A
  • Revenue
  • LEXX $496,923.00
  • BCG $161,721,000.00
  • Revenue This Year
  • LEXX $30.72
  • BCG N/A
  • Revenue Next Year
  • LEXX $31.85
  • BCG N/A
  • P/E Ratio
  • LEXX N/A
  • BCG N/A
  • Revenue Growth
  • LEXX 77.63
  • BCG N/A
  • 52 Week Low
  • LEXX $1.38
  • BCG $1.81
  • 52 Week High
  • LEXX $6.85
  • BCG $16.61
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 33.85
  • BCG N/A
  • Support Level
  • LEXX $1.38
  • BCG N/A
  • Resistance Level
  • LEXX $1.72
  • BCG N/A
  • Average True Range (ATR)
  • LEXX 0.12
  • BCG 0.00
  • MACD
  • LEXX -0.01
  • BCG 0.00
  • Stochastic Oscillator
  • LEXX 12.85
  • BCG 0.00

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About BCG Binah Capital Group Inc. Common Stock

Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.

Share on Social Networks: